JPRN-jRCT2031230023进行中(未招募)1 期
A phase 1 single-dose study of S-151128 in Japanese healthy adults
Gomez Juan Carlos0 个研究点目标入组 64 人开始时间: 2023年4月16日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中(未招募)
- 发起方
- 入组人数
- 64
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 <= 55age old(—)
- 性别
- All
入选标准
- •Aged 18 to 55 years, inclusive, at the time of informed consent.
- •-Apparently healthy in the opinion of the investigator at screening and on admission.
- •-Having Japanese parents.
排除标准
- •-Systolic blood pressure at rest falling outside the range of 90 to 140 mmHg or diastolic blood pressure falling outside the range of 50 to 90 mmHg, or pulse rate falling outside the range of 50 to 90 bpm at screening or admission and are considered ineligible for this study by the investigator.
- •-Current or a history of syncope of unknown cause, sick sinus syndrome, second or third degree atrioventricular block, myocardial infarction, pulmonary congestion, arrhythmia, angina pectoris, QT interval prolonged, or conduction abnormality.
- •-Current or a history of risk factors for Torsade de Pointes (eg, cardiac failure, cardiomyopathy, hypokalemia, family history of long QT syndrome, Brugada syndrome).
研究者
相似试验
未知
1 期
A phase 1, single-dose study of E6011 in Japanese healthy adult subjectsJPRN-jRCT2080221973Eisai Co., Ltd.64
未知
1 期
A Phase 1 Study of LY2875358 in Japanese Patients With Advanced MalignanciesSolid Tumors, LymphomaJPRN-jRCT2080221810Eli Lilly Japan K.K.
已完成
1 期
A Phase 1 Single Dose Study of E6011 in Japanese Healthy Adult Male Subjects (Study E6011-J081-001)Healthy Male VolunteersNCT01731275Eisai Co., Ltd.64
未知
1 期
A Phase 1 Single Dose Study of E6130 in Japanese Healthy Adult Male SubjectsJPRN-jRCT2080223305EA Pharma Co.,Ltd.68
已完成
1 期
A Single Dose Study of E6130 in Japanese Healthy Adult Male SubjectsJapanese Healthy Adult Male ParticipantsNCT02902978EA Pharma Co., Ltd.56
